Vitamin C Dosing in Renal Impairment

Standard Dosing Recommendations

The National Kidney Foundation recommends that patients with impaired kidney function limit their vitamin C intake to avoid oxalate accumulation, with combined dietary and supplemental intake kept conservative 1
Excessive vitamin C intake can result in increased oxalate concentrations in plasma and soft tissues, making high-dose supplementation particularly dangerous in renal impairment, according to the American Journal of Kidney Diseases 1
A dosage of 100 mg/day has been specifically suggested for patients with kidney disease as a safe upper limit, as recommended by Clinical Nutrition 2

Pediatric patients on dialysis may require lower supplemental doses of vitamin C, as infants on automated peritoneal dialysis receiving 140% of RDA from diet plus a 15 mg/day supplement reached 180% of RDA, as reported in the American Journal of Kidney Diseases 1
Malnourished dialysis patients with wounds should be tested for vitamin C deficiency and supplemented appropriately, typically with 100 mg/day, as recommended by Clinical Nutrition 3 is not preferred, instead: The American Society for Parenteral and Enteral Nutrition recommends that malnourished dialysis patients with wounds should be tested for vitamin C deficiency and supplemented appropriately, typically with 100 mg/day 3
For burn patients requiring massive resuscitation, high-dose ascorbic acid has been used, but this is in patients without significant renal dysfunction, as reported in Clinical Nutrition 4

The National Institute of Diabetes and Digestive and Kidney Diseases recommends that CKD Stage 1-4 patients (not on dialysis) limit their total vitamin C to 100 mg/day from all sources 2
Patients receiving prolonged renal replacement therapy should be monitored closely for signs of oxalate accumulation, as recommended by the American Society of Nephrology 3

The American Society for Parenteral and Enteral Nutrition recommends a standard maintenance dose of 100 mg/day as a safe upper limit for patients on chronic hemodialysis 5
For patients on Continuous Renal Replacement Therapy (CRRT), acute phase dosing of 2-3 g/day IV is recommended during critical illness 5, 6, 7

Daily effluent losses approximate 68 mg of vitamin C in patients on CRRT 6, 7
The National Kidney Foundation and National Institute of Diabetes and Digestive and Kidney Diseases provide Grade B evidence (strong consensus 100%) for monitoring and supplementing water-soluble vitamins including vitamin C in patients on kidney replacement therapy 6, 7

For pediatric dialysis patients, lower supplemental doses are required, with infants on automated peritoneal dialysis receiving 140% of RDA from diet plus only 15 mg/day supplement 8
In critical illness without renal dysfunction, a repletion dose of 2-3 g/day IV is recommended during the acute phase of inflammation 5

Electrolyte abnormalities must be closely monitored in patients with AKI or CKD receiving kidney replacement therapy 6, 7
Plasma vitamin C measurement is not recommended during critical illness or severe inflammation (CRP >10 mg/L) due to difficulty in interpretation 5

Hemodialysis patients should receive 100 mg/day of vitamin C as the safe upper limit for routine supplementation, with monitoring and replacement guided by serum levels and dialysis losses, as recommended by the Clinical Nutrition guidelines 9
Water-soluble vitamins, including vitamin C, must be monitored and supplemented in patients on kidney replacement therapy due to increased requirements and large effluent losses, according to the Clinical Nutrition guidelines 9, 10, 11

Hemodialysis patients lose approximately 68 mg of vitamin C daily in dialysate effluent during continuous renal replacement therapy, as reported by the Clinical Nutrition guidelines 9, 10, 11
Low vitamin C levels are consistently documented in hemodialysis patients due to restricted fruit intake and dialysis losses, as found by the American Journal of Kidney Diseases 12, 13

The ESPEN guidelines recommend 100 mg/day as the optimal dosing to balance replacement needs against toxicity risk 9
For patients on continuous renal replacement therapy during critical illness, a higher dose of 2-3 g/day IV may be necessary to account for increased utilization during critical illness, as suggested by the Clinical Nutrition guidelines 9, 10

Never exceed 100 mg/day in chronic hemodialysis patients to prevent oxalate accumulation, as warned by the Clinical Nutrition and American Journal of Kidney Diseases guidelines 9, 12, 13
Excessive vitamin C intake results in increased oxalate concentrations in plasma and soft tissues, as reported by the American Journal of Kidney Diseases 12, 13

Monitor serum vitamin C levels and adjust supplementation based on individual losses and clinical status, as recommended by the Clinical Nutrition guidelines 9, 10, 11
Plasma ascorbic acid levels reflect dietary intake, and leukocyte levels estimate total body pool, as found by the American Journal of Kidney Diseases 12, 13